Dynamic Technology Lab’s Ascendis Pharma A/S ASND Stock Holding History

Dynamic Technology Lab’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,890	Closed	-$299K	–	1083
2022 Q3	$299K	Buy	+2,890	New	+$274K	0.03%	806
2022 Q1	–	Sell	-1,910	Closed	-$257K	–	1093
2021 Q4	$257K	Buy	+1,910	New	+$284K	0.03%	863
2021 Q1	–	Sell	-2,101	Closed	-$350K	–	1130
2020 Q4	$350K	Buy	+2,101	New	+$347K	0.06%	591
2019 Q4	–	Sell	-4,469	Closed	-$430K	–	954
2019 Q3	$430K	Buy	+4,469	New	+$499K	0.08%	496

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dynamic Technology Lab's ASND Position: Q4 2022 in Review

Dynamic Technology Lab sold out of Ascendis Pharma A/S (ASND) in Q4 2022, closing a stake of 2,890 shares — an estimated $299K sold.

Dynamic Technology Lab first reported a position in ASND in Q3 2019 and held it in 4 quarters. The position peaked at $430K in Q3 2019. 187 funds tracked by Wall St. Rank hold ASND as of Q4 2022.

Dynamic Technology Lab reported no remaining Ascendis Pharma A/S position as of Q4 2022 after selling out during the quarter.
Dynamic Technology Lab sold 2,890 Ascendis Pharma A/S shares in Q4 2022, an estimated $299K.
Dynamic Technology Lab first reported a position in Ascendis Pharma A/S in Q3 2019 and held it in 4 quarters.
Dynamic Technology Lab's Ascendis Pharma A/S position peaked at $430K in Q3 2019.
187 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2022.

Based on Dynamic Technology Lab's 13F filing for Q4 2022, filed 14 Feb 2023.